Year: 2018
Type: article
Source: The Lancet Oncology
Authors: Stefano Fanti, Silvia Minozzi, Gerald Antoch, Ian Banks, Alberto Briganti, Ignasi Carrio, Arturo Chiti, Noel Clarke, Matthias Eiber, Johann De Bono, Karim Fizazi, Silke Gillessen, Sam Gledhill, Uwe Haberkorn, Ken Herrmann, Rodney J Hicks, Frederic Lecouvet, Rodolfo Montironi, Piet Ost, Joe M O'Sullivan, Anwar R Padhani, Jack A Schalken, Howard I Scher, Bertrand Tombal, R Jeroen A van Moorselaar, Heindrik Van Poppel, Hebert Alberto Vargas, Jochen Walz, Wolfgang A Weber, Hans-Jürgen Wester, Wim J G Oyen
Institutions: IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, University of Bologna, Regione Lazio, Heinrich Heine University Düsseldorf, European CanCer Organisation, Men's Health Forum, IRCCS Ospedale San Raffaele, Hospital de Sant Pau, Humanitas University, IRCCS Humanitas Research Hospital, The Christie Hospital, TUM Klinikum, Technical University of Munich, Institute of Cancer Research, Institut Gustave Roussy, University of Bern, Kantonsspital St. Gallen, University of Manchester, Movember Foundation, German Cancer Research Center, University Hospital Heidelberg, Essen University Hospital, Peter MacCallum Cancer Centre, Cliniques Universitaires Saint-Luc, UCLouvain, Marche Polytechnic University, Ghent University Hospital, Queen's University Belfast, Mount Vernon Hospital, Mount Vernon Cancer Centre, Radboud University Medical Center, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam, KU Leuven, Institut Paoli-Calmettes, National Health Service, Royal Marsden NHS Foundation Trust, NIHR Biomedical Research Centre at The Royal Marsden and the ICR
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Prostate Cancer Foundation, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Endocyte, Movember Foundation, Progenics Pharmaceuticals, Advanced Accelerator Applications, European Association of Nuclear Medicine, Cancer Research UK, Prostate Cancer UK, Astellas Pharma, Siemens Healthineers, Ipsen, Sirtex Medical, National Institutes of Health, Genentech, Stand Up To Cancer, Seventh Framework Programme, Sanofi Genzyme, National Cancer Institute, Cilag
OpenAlex ID: W2902543395